Loading stock analysis…
Evidence Synthesis
Last synthesized: 8 Jul 2026, 00:15
Evidence Synthesis
SUNPHARMA's 80.25% accelerated from 18.83%, while its 12.8% decelerated from 25.6%.
The company's count decreased from 20, and its shares moved from 3677980 shares. The stock's INR price decreased from 1912.8 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 80.25 % | 18.83 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 18.83 % | 19.64 | ▼ |
| REVENUE_GROWTH_YOY | 12.8 % | 25.6 | ▼ |
| EPS_ACTUAL | 11.975 INR | 13 | ▼ |
| EPS_SURPRISE_PERCENT | -0.048 % | 0.086 | ▼ |
| PRICE_CHANGE_PERCENT | -0.491 % | — | - |
| DAILY_VOLUME | 20,60,575 shares | 36,77,980 | ▼ |
| CLOSE_PRICE | 1,903.4 INR | 1,912.8 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.79 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 10 count | 20 | ▼ |
| TARGET_PRICE_PREMIUM | 7.56 % | — | - |